Thus, the probability that a patient was diagnosed with PCa in the long term was 4% if PSA was <0.51 μg/L increased to 41% when PSA levels were 2.01–3 μg/L, and peaked to >60% when levels exceeded 3 μg/L. This evidence concerns the gene KLK3 and posterior cortical atrophy.